Aquestive Therapeutics gets grant for enhanced pharmaceutical compositions for active component permeation

Discover how Aquestive Therapeutics' new patent enhances epinephrine delivery through innovative polymeric matrices, improving therapeutic applications and formulation versatility.

Related Posts

Pfizer licenses small molecule drug delivery technology...

Nov 20, 2023

Streamlining healthcare with AI for drug development

Jun 15, 2023

Birmingham University to develop lollipop for mouth can...

Mar 26, 2024